MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cgh.2025.01.015

Медицинская библиотека · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025

Worsening Disease Severity as Measured by I-SEE Associates With Decreased Treatment Response to Topical Steroids in Eosinophilic Esophagitis Patients.

Reed Craig C, LaFata Sean S, Gee Timothy S, Thel Hannah L, Cameron Brenderia A, Xue Angela Z, Kiran Akshatha, Ocampo Adolfo A, McCallen Justin, Lee Christopher J, Borinsky Stephanie A, Redd Walker D, Barlowe Trevor S, Kaakati Rayan N, Cotton Cary C, Eluri Swathi, Dellon Evan S

СтатьяПеревод в очереди

Аннотация

BACKGROUND & AIMS: The Index of Severity for Eosinophilic Esophagitis (I-SEE) grades eosinophilic esophagitis (EoE) severity across several domains. We assessed associations between EoE features and severity by I-SEE at diagnosis, and baseline I-SEE and outcomes following topical corticosteroids (tCS).

METHODS

We conducted a retrospective cohort study of newly diagnosed EoE patients. Data were extracted to complete the I-SEE at diagnosis. Disease activity was categorized as mild (I-SEE 1-6), moderate (I-SEE 7-14), or severe (I-SEE ≥15). We compared baseline characteristics by I-SEE category. We assessed if baseline I-SEE associated with treatment response in patients treated with tCS.

RESULTS

Of 1312 patients, there were 657 (50%), 461 (35%), and 194 (15%) with mild, moderate, and severe disease by I-SEE, respectively. Baseline scores were similar for children (8.5 ± 6.6) and adults (8.8 ± 6.5) (P = .37). Compared with mild or moderate disease, patients with severe disease were younger (23.8 ± 19.8 years for severe vs 28.0 ± 19.7 years for mild vs 30.3 ± 17.0 years for moderate; P < .001), had lower body mass index (21.6 ± 7.1 kg/m2 vs 24.4 ± 7.0 kg/m2 vs 25.7 ± 6.8 kg/m2; P < .001), and had longer symptom length preceding diagnosis (9.3 ± 10.5 years vs 5.9 ± 7.5 years vs 7.2 ± 7.9 years; P < .001). The baseline category associated with tCS response, with severe patients less likely to have histologic response (49% vs 55% vs 64%; P = .03 for <15 eosinophils per high-power field) and symptomatic responses, while also having the highest post-treatment eosinophilic esophagitis endoscopic reference scores.

CONCLUSIONS

I-SEE correlated with baseline features in a large EoE cohort, performed similarly in children and adults, and associated with post-treatment responses to tCS. These data support that I-SEE provides prognostic data and suggest that severe disease may benefit from intensive upfront management.

Для цитирования: Reed Craig C, LaFata Sean S, Gee Timothy S, Thel Hannah L, Cameron Brenderia A, Xue Angela Z, Kiran Akshatha, Ocampo Adolfo A, McCallen Justin, Lee Christopher J, Borinsky Stephanie A, Redd Walker D, Barlowe Trevor S, Kaakati Rayan N, Cotton Cary C, Eluri Swathi, Dellon Evan S. Worsening Disease Severity as Measured by I-SEE Associates With Decreased Treatment Response to Topical Steroids in Eosinophilic Esophagitis Patients.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2025. DOI: 10.1016/j.cgh.2025.01.015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.